BioSpace News Archive

Abiomed, a leader in breakthrough heart, lung and kidney support technologies, will feature the most recent Impella research and technological advances aimed at improving outcomes for acute myocardial infarction cardiogenic shock patients during the Society for Cardiovascular Angiography and Interventions 2022 Scientific Sessions, May 19 – 22, in Atlanta.

Evolus, Inc., a performance beauty company with a customer-centric approach focused on delivering breakthrough products, celebrates the three-year anniversary of the launch of its flagship neurotoxin product, Jeuveau®, the first and only neurotoxin dedicated exclusively to aesthetics.

Regencell Bioscience Announces Additional EARTH Efficacy Trial Results Corroborating Effectiveness of its Investigational Liquid-Formula RGC-COV19 TM in Eliminating Mild to Moderate COVID-19 Symptoms within the 6-Day Treatment Period.

AVEO Oncology announced that members of its senior management team will participate in a fireside chat at the H.C. Wainwright Global Investment Conference on Wednesday, May 25, 2022 at 1:30 p.m. eastern time.

Kane Biotech Inc., announced that it has obtained ISO 13485:2016 certification for its quality management system specific to its ongoing efforts to design and develop novel medical devices for the wound care market.

Veru Inc. (NASDAQ: VERU), a biopharmaceutical company focused on developing novel medicines for COVID-19 and other viral and ARDS-related diseases and for the management of breast and prostate cancers, today announced the appointment of Joel Batten as Executive Vice President and Head of its U.S. Infectious Disease Franchise effective May 23, 2022.

ChemoCentryx, Inc., (Nasdaq: CCXI), today announced that a poster will be presented at the Society for Investigative Dermatology (SID) 2022 Annual Meeting, to be held May 18-21, 2022 in Portland, Oregon, that highlights unique immunological profiles of the subdermal tunnels in hidradenitis suppurativa, and how these profiles are differentiated with the stage of disease severity.

Fortress Biotech, Inc. announced that Lindsay A. Rosenwald, M.D., Chairman, President and Chief Executive Officer, will participate in two investor conferences in May 2022.

Senti Bio, a leading gene circuit company, today announced three presentations at the American Society of Gene and Cell Therapy (ASGCT) annual meeting being held in Washington D.C., May 16–19, 2022.

Evoke Pharma, Inc. (NASDAQ: EVOK), a specialty pharmaceutical company focused on treatments for gastrointestinal (GI) diseases, and EVERSANA™, a leading provider of global commercial services to the life science industry, today announced positive findings from the first patient-centered survey related to GIMOTI.